Quantcast

Tag Archives: Paxil

Glaxo settles marketing fraud charges for record $3 billion

GlaxoSmithKline has agreed to plead guilty and pay $3 billion to resolve charges that the pharmaceutical giant fraudulently marketed the prescription drugs Paxil, Wellbutrin and Avandia, the U.S. Justice Department has announced.

Read More »

Drug litigation in review 2010

Much like 2009, 2010 was a busy year for prescription drug suits.

Read More »